Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

Flavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...

Under the terms of the agreement, OPKO will accept 60% of the development costs, while Entera will shoulder 40%.

Liraglutide is a peptide that has gained significant attention in scientific research due to its structural similarity to ...

Insulin resistance occurs when the body's cells become less responsive ... Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone that plays a vital role in glucose ...